Search research articles
Contact Us
Filters
Showing results (81-90 of 141) with videos related to
Page
of 15
Sort By:
The Journal of Clinical Investigation
|
June 1, 1992
Involvement of integrin alpha V gene expression in human melanoma tumorigenicity
B Felding-Habermann, B M Mueller, C A Romerdahl, et al.
The Journal of Cell Biology
|
June 1, 1992
Requirement of the integrin beta 3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen
D I Leavesley, G D Ferguson, E A Wayner, et al.
Cancer Research
|
December 1, 1986
Potentiation of lymphocyte responses by monoclonal antibodies to the ganglioside GD3
P Hersey, S D Schibeci, P Townsend, et al.
The Journal of Clinical Investigation
|
July 15, 1996
Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis
S Strömblad, J C Becker, M Yebra, et al.
The Journal of Cell Biology
|
April 1, 1991
Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells
N Kieffer, L A Fitzgerald, D Wolf, et al.
Endocrinology
|
June 1, 1996
Osteopontin activation of c-src in human melanoma cells requires the cytoplasmic domain of the integrin alpha v-subunit
M Chellaiah, C Fitzgerald, E J Filardo, et al.
The Journal of Cell Biology
|
October 31, 2001
Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins
D G Stupack, X S Puente, S Boutsaboualoy, et al.
Journal of Cell Science
|
March 1, 1995
Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors
C L Gladson, J N Wilcox, L Sanders, et al.
The Journal of Cell Biology
|
July 1, 1995
Requirement of the NPXY motif in the integrin beta 3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo
E J Filardo, P C Brooks, S L Deming, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1985
Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis
D A Cheresh, C J Honsik, L K Staffileno, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 141) with videos related to
Sort By:
Page
of 15
The Journal of Clinical Investigation
|
June 1, 1992
Involvement of integrin alpha V gene expression in human melanoma tumorigenicity
B Felding-Habermann, B M Mueller, C A Romerdahl, et al.
The Journal of Cell Biology
|
June 1, 1992
Requirement of the integrin beta 3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen
D I Leavesley, G D Ferguson, E A Wayner, et al.
Cancer Research
|
December 1, 1986
Potentiation of lymphocyte responses by monoclonal antibodies to the ganglioside GD3
P Hersey, S D Schibeci, P Townsend, et al.
The Journal of Clinical Investigation
|
July 15, 1996
Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis
S Strömblad, J C Becker, M Yebra, et al.
The Journal of Cell Biology
|
April 1, 1991
Adhesive properties of the beta 3 integrins: comparison of GP IIb-IIIa and the vitronectin receptor individually expressed in human melanoma cells
N Kieffer, L A Fitzgerald, D Wolf, et al.
Endocrinology
|
June 1, 1996
Osteopontin activation of c-src in human melanoma cells requires the cytoplasmic domain of the integrin alpha v-subunit
M Chellaiah, C Fitzgerald, E J Filardo, et al.
The Journal of Cell Biology
|
October 31, 2001
Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins
D G Stupack, X S Puente, S Boutsaboualoy, et al.
Journal of Cell Science
|
March 1, 1995
Cerebral microenvironment influences expression of the vitronectin gene in astrocytic tumors
C L Gladson, J N Wilcox, L Sanders, et al.
The Journal of Cell Biology
|
July 1, 1995
Requirement of the NPXY motif in the integrin beta 3 subunit cytoplasmic tail for melanoma cell migration in vitro and in vivo
E J Filardo, P C Brooks, S L Deming, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 1, 1985
Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis
D A Cheresh, C J Honsik, L K Staffileno, et al.
Page
of 15